Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against TG Therapeutics, Inc. (TGTX)

Wednesday, October 10, 2018 Medico Legal News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 10, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and

consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against TG Therapeutics, Inc. ("TG" or the "Company") (NASDAQ: TGTX) and other defendants, related to alleged violations of federal securities laws.  If you purchased TG Therapeutics securities between June 4, 2018 and September 25, 2018, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information

TG is a developmental biopharmaceutical company focused on treatments for B-cell malignancies and autoimmune diseases. The Company has been developing two therapies targeting hematologic malignancies: TG-1101 (ublituximab) and TGR-1202 (umbralisib).

During the class period, TG was engaged in a randomized controlled Phase 3 trial to evaluate TG-1101 in combination with TGR-1202 for patients with front-line and previously treated Chronic Lymphocytic Leukemia ("CLL"), known as the UNITY-CLL Trial.

The lawsuit alleges that defendants made false and misleading statements regarding TG's business and prospects and the UNITY-CLL Trial.

On September 25, 2018, pre-market, TG announced that it would not be releasing the data from the UNITY-CLL Trial and that it had failed to meet the trial's stated goal.

On this news, the price of TG stock fell from $9.25 per share to $5.15 per share – a drop of over 44%.

What You Can Do

If you purchased TG Therapeutics securities between June 4, 2018 and September 25, 2018, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com.  The lead plaintiff deadline is December 3, 2018.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

CONTACT:

Joe PettigrewScott+Scott Attorneys at Law LLP230 Park Ave, 17 Fl, NY, NY 10169-1820(844) 818-6982jpettigrew@scott-scott.com

 

Cision View original content:http://www.prnewswire.com/news-releases/scottscott-attorneys-at-law-llp-alerts-investors-to-securities-class-action-against-tg-therapeutics-inc-tgtx-300728804.html

SOURCE Scott+Scott Attorneys at Law LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store